MMP9 and Cerebral ischemia: 3,5-di-CQA protects the blood-brain barrier from damage induced by cerebral ischemia by lowering iNOS expression, suppressing ROS/RNS generation, MMP-9 transcription and synthesis, and reducing MMP-9 degradation mechanisms on claudin-5, occludin, and ZO-1 [28].